MONOCLONAL ANTIBODY SPECIFIC TO HEART-TYPE FATTY ACID BINDING PROTEIN, HYBRIDOMA CELL PRODUCING SAME, AND PRODUCTION METHOD THEREOF
The present invention refers to h a-FABP(heart a-type fatty acid binding protein) and hybridoma cell line producing a monoclonal antibody that specifically bind to provided the presence of manufacturing method relates to a fatty acid binding specifically recognizing myocardial to an h a-FABP mouse monoclonal antibody producing hybridoma cell line and its manufacturing method relates to, said myocardial injury to the blood of a monoclonal antibody detecting diagnosing acute myocardial infarction treating eluted h a-FABP can be useful. 3 Acute myocardial infarction myocardial oxygen supply for supplying oxygen to provide the means by which one of various causes are closed or related even coronary heart diseases is not myocardial necrotic supplied nutrients and oxygen are disclosed. 30 Minutes after coronary artery is closed and long-term myocardial is necrosis begins, 6 hours much of the myocardial necrosis is etched (kim eastern annularity in addition, acute myocardial infarction in the diagnosis CK-a MB on Troponin simultaneously checks whether a macro, non-emergency medical bulletin, 2009; 20:264 - 271). The chest pain but such as acute myocardial infarction mortality reaching 30% initial pain aspects similar disorders since early diagnosis and the correct identification more difficult (kim zero it gave out, emergency room to is how the acute myocardial infarction in patients h a-FABP diagnostic significance, non-emergency medical bulletin, 2009; 20:163 - 169) conditions appropriate times after passing the exhaust pipe diagnosis or prognosis of tumor treatment if not death state is to provide a flow tides. The patient's treatment of acute myocardial infarction to diagnose an early stage through the prognosis for survival of a nice expected important disclosed. These include myocardial infarction marker of user [nin with CK-a MB, etc. american five globin. The american five globin ischemic damage to myocardial tissue which has been subjected to concentration in the blood discharged from fast increases blood starts to time before and after the time 2 6 - 9 operable to stop operation but, even in large amounts of other diseases or skeletal muscle exists since even muscle damage attributable to the specific myocardial infarction was the traffic for to tame. These [...] I, T, 3 of which in particular I T is present on the relative C specific user an indicia for use much current is double in myocardial tissue is but, in the sense that door number 3 - 6 which rises to the threshold time returning [...] flow tides. H a-FABP is first found by 1972 years compared the Ockner 15kDa molecular weight fatty acid binding protein cleaner is the formula 1 protein, etc. have been enriched to the recipient cytoplasm mainly cell can be applied to distribution. Small molecular weight 1 is provided with a blood cell can be applied to damage the loose velocity generating conditions. 5 Hours after 6 - 8 concentration in blood concentration in blood from reaching the time which screw begins to lift up and quickly so as to convert a myocardial infarction marker useful as an indicator of early diagnosis other than (Chan et al, A superior early myocardial infarction marker. Human heart a-type fatty acid a-binding protein, [Preceding patent document] A compensation patent publication number 10 - 2014 - 0015153 The present invention refers to said door solving point number, by eliminating the need for said battery is provided, the purpose of the invention is allowing the user to myocardial infarction to take appropriate medical diagnosis to [...] number monoclonal antibodies are disclosed. It is another object of the present invention appropriate medical diagnosis to take the user to myocardial infarction to [...] number hybridoma lines producing monoclonal antibodies are disclosed. In order to achieve said purposes of the present invention refers to strain is produced from hybridoma cells or KCLRFBP 00361 KCLRFBP 00362, heart-type fatty acid bond protein specific monoclonal antibodies (h a-FABP; heart a-type fatty acid binding protein) number [...] substrate. In the present invention refers to said of the present invention antibodies including a number kit for diagnosing myocardial infarction [...] substrate. In the present invention refers to said present invention by monoclonal antibodies including myocardial infarction diagnostic strip number [...] substrate. In one embodiment of the present invention, said diagnostic strip is gold particles, the rule five [su which it will count nitro membrane of the present invention immobilized antibodies preferably are inserted S. limited. In the present invention refers to said present invention for diagnosing myocardial infarction by monoclonal antibodies including antibody sensitized latex reagent number [...] substrate. In one embodiment of the present invention, insoluble polystyrene latex particles of the present invention for diagnosing said latex antibody sensitized reagents are immobilized antibody preferably, Antibody sensitized latex reagent for diagnosing said latex particle size 0. 01Um-a 0. 5Um and preferably, Said diagnosis for their production antibody sensitized reagents are measured by corresponding syndrome according to Claim 1 antibodies to antigens of latex particle agglutination reaction preferably increase inspection by optically measuring the limited holes which are disclosed. In the present invention refers to said of the present invention monoclonal antibody method number information about the number of myocardial infarction [...] substrate. In the present invention refers to said of the present invention using a kit for diagnosing myocardial infarction [...] method number information about the number [...] substrate. In the present invention refers to said of the present invention a method for diagnosing myocardial infarction using number information about the number strip [...] substrate. In the present invention refers to said of the present invention a method for diagnosing myocardial infarction using an assay reagent antibody sensitized latex [...] number information about the number [...] substrate. In the present invention refers to said of the present invention monoclonal antibodies including heart-type fatty acid bond protein active ingredient (h a-FABP; heart a-type fatty acid binding protein) composition for detecting number [...] substrate. The present invention refers to said of the present invention monoclonal antibodies in whole blood, serum, or plasma sample method for detecting a heart-type fatty acid bond protein (h a-FABP; heart a-type fatty acid binding protein) number [...] substrate. Antigen - antibody combined immune response using said diagnostic strip for diagnosing a disease immunochromatographic method for plural times. Nitro cellulose membrane between the strip of gold particles and other fixing antibodies antibodies of high pressure liquid coolant into a number one number after a diagnostic strip conjugates processes using high pressure liquid coolant, synchronizing nitro cellulose film sample in sword body pad moves along the base. Antibodies of gold particle conjugates in conjunction with cellulose film after antigen conjugates pad - alkoxy carbonyl while moving inspection line secured to the gold particle color ray appearing in combination with antibodies (Test Line) making use of the diagnosis of acute myocardial infarction can be. Said antibody sensitized latex reagent for diagnosing the non- [thak law immune antigen - antibody response is measured for plural times. Insoluble particles of the present invention antibodies (R2) syndrome after being mixed with a high pressure liquid coolant sample number (R1) stable reagents anger misfortune addition antigen when present in a latex particle aggregate and increased turbidity can be optically measuring the diagnosis of acute myocardial infarction. Hereinafter the present invention is described as follows. The present invention is labeled myocardial damages said victims of the algorithm to extract specific time and is capable of detection in blood concentration can be useful for early diagnosis of myocardial infarction is decreased h a-FABP cell lines producing monoclonal antibodies and monoclonal antibody specifically detected a his invention. The present invention can be useful for early diagnosis of myocardial infarction is turned h a-FABP h a-FABP the full length protein, its fragments and mutants material which, in one embodiment the sequence numbers 1 protein has an amino acid sequence of be a. The present invention refers to h a-FABP immunizing a mouse monoclonal antibodies that specifically bind to the step h a-FABP and the corresponding hybridoma cell line specific for mouse monoclonal antibodies produced from hybridoma cell line h a-FABP number [...] substrate. First recombinant h a-FABP among the mouse spleen cells after immunisation of SP2/0 mouse myeloma cells extracted therefrom exhibit a specific ELISA (Enzyme non-linked immunosorbent assay) fusion cells clone h a-FABP characterized by selecting other. Mouse hybridoma cells of said selected procedure of the present invention 1G 4, and 3F 2 and are referred to, Seoul Korea research studies in cancer cell lines (KCLRF) copper Seoul Savina yearly case manager in a compensation special at the time of each strain was filed 21 March 2016 to KCLRFBP 00361 KCLRFBP 00362 and cutting. H a-FABP produced from hybridomas of the present invention selectively recognizing antigen specificity angptl4 not the multimode interference coupler on said monoclonal antibody fusion protein GST h a-FABP and voice matching of the troop BSA reactive ELISA technique has been confirmed. As a result, said monoclonal antibodies specifically bind to antigen recognition ability which shows high h a-FABP were identified. Of the present invention mouse hybridoma cells producing monoclonal antibody is present in blood can be used to detect early diagnosis myocardial infarction h a-FABP. The present invention refers to a high concentration in the blood immediately after myocardial damages quickly forming h a-FABP high sensitivity, monoclonal antibodies capable of specifically binding to said number of hybridoma cell line for producing comprises producing monoclonal antibodies. In to the diagnosis of acute myocardial infarction onset time after diagnosis to shorter buckle supporter of the present invention h a-FABP reception since the prognosis of tumor treatment for acute myocardial infarction accurate specific monoclonal antibodies can be useful for early diagnosis. Figure 1 shows a number of the monoclonal antibodies of the present invention h a-FABP also specifically bind to indicating a start point during are disclosed. Figure 2 h a-FABP 1G 4 clones producing monoclonal antibodies specific for mouse abdominal cavity after culture in 3F 2 clone and riding on the positive number result caused by Affinity column chromatography method are disclosed. Figure 3 positive number b5r antibodies (1G 4, 3F 2) ELISA for binding specificity and titer of h a-FABP is confirmed result is a graph. Figure 4 number produced therewith specifically bind to the monoclonal antibodies by an h-a FABP immunochromatographic palladium and a small test result number are disclosed. Figure 5 h a-FABP specific monoclonal antibodies latex reagent for the quantitative measurement of curve syndrome are disclosed. The present invention non-limiting in the embodiment hereinafter through more detailed as follows. The present invention is to end in the embodiment of the present invention range in the embodiment described as intended is exemplified that the number represented by one interprets the holes which are disclosed. In the embodiment 1: Recombinant h -FABP Number bath IRB B hospital patient sample in the table 1 with cardiac related security protection material through 95 °C 30 seconds for primer using, 53 °C 30 seconds, 72 °C 1 to 35 minutes (USA) yarn conducting PCR using Biorad circulation device. PCR execution Hot Start Taq PCR MasterMix (Bioquest, USA) is 0. 4UM embodiment using primer and, in which is obtained a target DNA agarose gel electrophoretic about 400bp size has been confirmed. BL21 (DE3) after cloning using pGEX-a 4T 1 vector having same GST fusion persimmons transformed (codon +) after selecting his FABP3-a pGEX-a BL21 codon plus. A recombinant strain transformed with 50 micro g/ml LB containing [aym the phosphorus which will bloom (FABP3-a pGEX-a BL21 (codon +)) of liquid medium is provided which reduces, freely cultivation-gate 37 °C 16 hours or more. Similarly [aym the phosphorus which will bloom LB medium containing liquid medium having an amount reference 2 times to 1/50 volume ratio 37 °C to 600 nm while cultured in the culture of said inoculated flasks absorbance at 0. 7 Reaches a final concentration of 1 mm IPTG induction conditions respectively have agents embodiment, induction during a period from 4 by him as further each time. 4 °C culture expressed, in centrifugal separator 16, 000xg 3 minutes by repeating the process that were unsafe. Cells (Novagen, USA) per 5 ml of bug 1g contact portions may not be separated by adding protein extract solution using a supernatant after FPLC suspended in a positive number which gives rise to raw material upon him. In the embodiment 2: Mouse of immunizing Number hybridoma cells required to obtain the connection immunization of the bath, a phosphate buffer solution (phosphate buffered saline; PBS) to 100 micro l recombinant h a-FABP 100 micro g at the same dilution (complete Freund's adjuvant, Sigma) emulsion was mixed with a high pressure liquid coolant volume of CFA number. 5 Female BALB/c mouse abdominal cavity with said emulsion by using immunization work conducting 1 week zero difference. In order to enhance the immunity of a mouse after immunization such as behind a 14 1 difference amount of recombinant h a-FABP IFA (Incomplete Freund's adjuvant, Sigma) total 3 times 2 mouse abdominal cavity after said number tank emulsion by mixing it with main scanning intervals stored in the immune response. 3 Cell line a phosphate buffer solution (phosphate buffered saline; PBS) recombinant h a-FABP 100 micro g number tank before the mouse tail vein to a scanning frequency of 100 micro l dilution to him. In the embodiment 3: H -FABP Producing specific monoclonal antibodies Hybridomas Cell number bath The SP2/0 mouse myeloma cells (myeloma) cell lines for supplying life science and biochemical laboratory cell fusion before university completed) him as first. After immunized mouse spleen cells in spleen SP2/0 mouse myeloma cell line is therefore of 2:1 is first prepared by extracting so mixed. Then, the supernatant after centrifuging the mixed cell misfortune stand-alone a number added to a 1 ml 1 minutes PEG-a 1500 (polyethylene glycol-a 1500) was embodiment fusion cells. Fused cells cultured in 96 well plate have HAT selection, cell colony was cultured in HT heating is formed. In the embodiment 4: Monoclonal antibodies Producing Hybridomas Cell sorting and Cloning In high pressure liquid coolant in the embodiment 3 number hybridoma cells microscopes cells continue observing the bottom of each well 10 - 20% NaOCl NaOCl degree, in order to identify whether h a-FABP reacts specifically only antibodies of hybridoma cells was by performing ELISA (Enzyme non-linked immunosorbent assay). 96 Well plate cell line culture into 100 micro l/well less attention then h a-FABP antigen by reacting, anti mouse IgG HRP (horse raddish peroxidase) on with respect to the reaction product. Then adding substrate solution, ELISA reader (BioRad) in 450 nm absorbance using cell lines was measured at least selecting SnO 1 1 absorbance. 1 Difference number selected for hybridoma cells after dilution ELISA performed identically to a test object a method performing hybridoma cells exhibiting high absorbance difference selection result 2 2 a method of selecting his species. Finally selected for hybridoma cells culture is transferred 75 T/C culture flasks, each 1G 4, 3F 2 was referred to. In the embodiment 5: Selected for Hybridomas H - fromFABP Specific Monoclonal antibody Production H a-FABP in the embodiment 4 to obtain specific monoclonal antibodies selected for hybridoma cells in culture number mouse abdominal cavity and high pressure liquid coolant, antibodies was separating therefrom. A plurality liquid to obtain first antibodies (ascites) in advance before the BALB/c mouse hybridoma cells intraperitoneally (pristane) compositions comprising scanning a column scanning micro l/mouse was 500. In the embodiment 4 in 7 - 10 days post-administration selected for hybridoma cells in 75 T/C free compositions comprising mouse intraperitoneally was discharged through a scanning frequency of the culture flasks. 7 - 14 Days post-within the mouse abdominal cavity (ascites) are respectively determined, after the mask it boils each mouse using a cervical syringe plurality that were unsafe. Retrieving the plurality to separate and recover only supernatant by centrifuging to produce his -20 °C for archiving. In the embodiment 6: H -FABP Specific Of the monoclonal antibodies Positive number In the embodiment 5 (ascites) is recovered using affinity column chromatography method was positive to a plurality protein G column number. Ammonium sulfate fractionation (ascites) precipitating a plurality first recovered before positive number (GE health care, HiTrap protein G HP) after passing the epithelial eluent buffer Protein G column (elution buffer, 100 mm glycine a-HCl, pH 2. 7) Are separated from each other using, finally monoclonal antibody positive number was complete. (2 Also) In the embodiment 7: Hybridomas Produced from cells Of the monoclonal antibodies H -The FABP Binding specificity for identifying Of the present invention hybridoma cells (1G 4, 3F 2) produced from h a-FABP angptl4 selectively recognizing in order to identify binding specificity is confirmed to ELISA (Enzyme non-linked immunosorbent assay). H a-FABP voice controls include BSA and GST fusion protein coating on recombinant buffer (0. 05M Na-a cabonate, pH 9. 5) 96 Well ELISA plate to 1 ug/ml concentration after each [...] mixed and are expanded, 0 same. Buffer solution including 5% phosphorus was to block the car number. After this, a stand-alone solution after said number of the present invention hybridoma cells (1G 4, 3F 2) by reaction in the embodiment 4 monoclonal antibody produced from recombinant antigens against the method identical to the monoclonal antibody recognition ability of h a-FABP were measured. As a result, hybridoma cells of the present invention (1G 4, 3F 2) voice matching of the troop BSA and GST would monoclonal antibody fusion proteins which comprise a little recognition by screening for antigen recognition capability without recombinant h-a FABP3 high shown. (3 Also) Table 2 and 3 is monoclonal antibody (1G 4, 3F 2) of h a-FABP identifying for binding specificity and titer {Antigen: ng/ml} In the embodiment 8: Monoclonal antibodies Diagnostic use Kit Number bath and test H a-FABP in high pressure liquid coolant in the embodiment 6 a number specific monoclonal antibody (1G 4) 1 mg/ml concentration by utilizing dividers nitro cellulose membrane on a mouse IgG anti - 37 °C after 10 in a continuous division number was dried and generates a high pressure liquid coolant antibody fastening strips. Other monoclonal antibody (3F 2) is 0. Concentration 1 mg/ml to 30 minutes at room temperature with respect to the gold particle and reaction. 30 Minutes into a reaction solution 1% BSA to further reacted with 1% BSA buffer solution and then centrifuging the precipitate dissolves gold particle conjugates was reconstituted with a stand-alone number number antibody - high pressure liquid coolant. The high pressure liquid coolant - gold particle conjugates number antibodies fixing strip antibody immune chromatography palladium number was a high pressure liquid coolant. H a-FABP is detected using a voice recombinant h a-FABP on serum results to identify limit detection sensitivity can be about 7 ng/ml has been. (4 Also) In the embodiment 9: Anger misfortune of stable (hereinafter R1) Number bath 75 Mm HEPES buffer (pH 8. 0) BSA to a 0. R1 to a dicarboxylic acid 5% are obtained. In the embodiment 10: Insoluble Carrier Fixing antibodies Sensitization Reagent (hereinafter R2) number of bath 10 Mg of 2% latex solution latex of the present invention monoclonal antibodies per 750ug MES buffer (pH 5. 8) 3 In stirring time-gate. 2% BSA blocking time after adding 1 is so agitating centrifuging the latex Tris a-HCl buffer (pH 8. 5) Is suspended in R2 are obtained. In the embodiment 11: A h - latex reagentsOf FABP Quantitative In the embodiment 9 10 via a number of R1 and R2 on high pressure liquid coolant using solution of automatic analyzer (Beckman Coulter AU680) were measured to agglutination reaction with h a-FABP. 450 Nm wavelength to the livestock products was also a result of the determination such as 5 in Figure 0 160 ng/mL h a-FABP measurable. <bio-deposit id="biod-00001" num="0001"><depositary>Korean cell line studies cutting</depositary><bio-accno>KCLRFBP 00361</bio-accno><date>20160321</date></bio-deposit><bio-deposit id="biod-00002" num="0002"><depositary>Korean cell line studies cutting</depositary><bio-accno>KCLRFBP 00362</bio-accno><date>20160321</date></bio-deposit> The present invention relates to a monoclonal antibody specifically recognizing heart-type fatty acid binding protein (h-FABP), a hybridoma cell line producing the monoclonal antibody, and a production method thereof. The monoclonal antibody shows high titration for h-FABP in blood and specifically binds to the same, thereby being used for a diagnostic kit to detect h-FABP. COPYRIGHT KIPO 2017 Strain is produced from hybridoma cells or KCLRFBP 00361 KCLRFBP 00362, heart-type fatty acid bond protein specific monoclonal antibody (h a-FABP; heart a-type fatty acid binding protein). According to Claim 1 antibodies including kit for diagnosing myocardial infarction. By monoclonal antibodies including anti number 1 myocardial infarction diagnostic strip. According to Claim 3, said diagnostic strip is gold particles, characterized in that the rule five [su which it will count nitro membrane according to Claim 1 antibodies immobilized a myocardial infarction diagnostic strip. By monoclonal antibodies including antibody sensitized latex reagent for diagnosing myocardial infarction anti number 1. According to Claim 5, said polystyrene latex particles immobilized antibody sensitized latex for diagnosing the sparingly water-soluble reagents are antibodies according to Claim 1 characterized in that the antibody sensitized latex reagent. According to Claim 5, particle size of the latex reagent for diagnosing said antibody sensitized latex 0. 01Um-a 0. 5Um characterized antibody sensitized latex reagent. According to Claim 5, said diagnosis for their production antibody sensitized reagents are measured by corresponding according to Claim 1 antibodies to antigens of latex particle agglutination reaction syndrome characterized by optically measuring the immunological reagent for assaying an increase inspection The method according to Claim 1 monoclonal antibody [...] number information about the myocardial infarction. The method according to Claim 2 using information about number [...] kit for diagnosing myocardial infarction. Using information about the number [...] method according to Claim 3 strip for diagnosing myocardial infarction. According to Claim 5 antibody sensitized latex for diagnosing myocardial infarction using an assay reagent [...] number information about the method. According to Claim 1 monoclonal antibodies including active ingredient composition for detecting heart-type fatty acid bond protein (h a-FABP; heart a-type fatty acid binding protein). According to Claim 1 monoclonal antibody whole blood, serum, or plasma sample method for detecting heart-type fatty acid bond protein (h a-FABP; heart a-type fatty acid binding protein). A forward primer GC GGA TCC ATG GTG GAC GCT TTC (seq ID 2) Reverse primer CG GTC GAG TCA TGC CTC TTT CTC (seq ID 3) 1G 4 10000 1000 100 10 1 H a-FABP 1. 728 1. 691 1. 234 0. 564 0. 232 BSA 0. 090 0. 080 0. 080 0. 082 0. 080 GST 0. 059 0. 058 0. 065 0. 066 0. 051 3F 2 10000 1000 100 10 1 H a-FABP 1. 637 1. 605 1. 324 0. 638 0. 378 BSA 0. 092 0. 076 0. 095 0. 086 0. 070 GST 0. 057 0. 052 0. 051 0. 061 0. 066